MedTrace Logo

Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating Room

NCT00366015 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-08-28

No results posted yet for this study

Summary

This study will combine coronary stenting with minimally invasive robotic coronary bypass surgery, accomplished with the use of the da Vinci robot, to restore blood flow to occluded coronary arteries. Two previously approved and commonly performed procedures used to treat coronary artery disease(coronary stenting and robotic bypass surgery) are being combined into a hybrid surgery in a specialty built operating room. Patients with low risk coronary lesions will undergo cardiac hybrid revascularization using stenting and LIMA to LAD robotic bypass concomitantly. Patients' postoperative bleeding rates, angiographs and complication free rates will be recorded.

Conditions

Interventions

PROCEDURE

Robotic-assisted Coronary Surgical Revascularization

Robotic assistance of coronary artery bypass grafting using the DaVinci surgical robotic console

PROCEDURE

PCI- Drug Eluting Stents

Drug eluting stents performed by cardiologist within the same operating theatre following robotic assisted coronary artery bypass surgery

Sponsors & Collaborators

  • Canada Foundation for Innovation

    collaborator OTHER

  • Ontario Innovative Trust

    collaborator UNKNOWN

  • Ontario Research and Development Challenge Fund

    collaborator OTHER

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Bob Kiaii, MD, FRCSC · Department of Cardiac Surgery, University of Western Ontario and the London Health Sciences Centre, University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-29
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00366015 on ClinicalTrials.gov